IP Library Assignment 066157/0079
Patent Assignment
Reel/Frame 066157/0079

Security Interest

Recorded: 2023-12-28 Pages: 42
Assignors
JOURNEY MEDICAL CORPORATION
Executed: 2023-12-27
JG PHARMA, INC.
Executed: 2023-12-27
Assignee
SWK FUNDING LLC
5956 SHERRY LANE. SUITE 650, DALLAS, TEXAS, 75225
Covered Properties (78)
Roll-On Applicators and Methods for Treating Dermal Conditions
Application: 17/506,343 →
Publication: US US20220118236A1
Methods for treating inflammatory skin conditions
Application: 17/844,715 →
Publication: US US20230131030A1
Glycopyrrolate Salts
Application: 17/713,221 →
Publication: US US20220233500A1
Methods for Palmar or Plantar Administration of Pharmaceutical Compositions
Application: 17/774,850 →
Publication: US US20220401412A1
Topical Glycopyrrolate Formulations
Application: 18/142,409 →
Publication: US US20230270631A1
Surfactant-Free Water-Free Foamable Compositions, Breakable Foams and Gels and Their Uses
Application: 16/948,631 →
Publication: US US20210015927A1
Topical Tetracycline Compositions
Application: 16/805,201 →
Publication: US US20200261586A1
Surfactant-Free, Water-Free Foamable Composition and Breakable Foams and Their Uses
Application: 17/066,752 →
Publication: US US20210023226A1
Compositions, Gels and Foams with Rheology Modulators and Uses
Application: 17/806,354 →
Compositions, Gels and Foams with Rheology Modulators and Uses Thereof
Application: 18/153,604 →
Compositions, Gels and Foams with Rheology Modulators and Uses
Application: 18/472,825 →
Compositions, Gels and Foams with Rheology Modulators and Uses Thereof
Application: 17/804,121 →
Compositions, Gels and Foams with Rheology Modulators and Uses Thereof
Application: 17/804,141 →
Compositions, Gels and Foams with Rheology Modulators and Uses Thereof
Application: 18/150,037 →
Compositions, Gels and Foams with Rheology Modulators and Uses Thereof
Application: 18/153,414 →
Compositions, Gels and Foams with Rheology Modulators and Uses Thereof
Application: 18/456,612 →
Publication: US US20240252647A1
Compositions, Gels and Foams with Rheology Modulators and Uses Thereof
Application: 18/462,080 →
Publication: US US20240252648A1
Compositions for the Improved Treatment of Acne and Related Disorders
Application: 17/025,156 →
Publication: US US20210077509A1
Compositions for the Improved Treatment of Acne and Related Disorders
Application: 17/936,562 →
Publication: US US20230270760A1
Stable Topical Tetracycline Compositions
Application: 16/624,244 →
Publication: US US20230123488A1
Compositions and Methods and Uses Thereof
Application: 17/597,892 →
Publication: US US20230346805A1
Crystalline Glycopyrrolate Tosylate
Patent: 8,558,008 →
Application: 13/781,390 →
Publication: US US20130211101A1
Crystalline Glycopyrrolate Tosylate
Patent: 9,006,461 →
Application: 14/024,480 →
Publication: US US20140243535A1
Crystalline Glycopyrrolate Tosylate
Patent: 8,859,610 →
Application: 14/024,484 →
Publication: US US20140242122A1
Glycopyrrolate Salts
Patent: 9,006,462 →
Application: 14/473,537 →
Publication: US US20140371290A1
Glycopyrrolate Salts
Patent: 9,259,414 →
Application: 14/643,553 →
Publication: US US20150196532A1
Glycopyrrolate Salts
Patent: 9,610,278 →
Application: 14/989,995 →
Publication: US US20160113902A1
Glycopyrrolate Salts
Application: 15/438,636 →
Publication: US US20170157088A1
Glycopyrrolate Salts
Application: 15/996,353 →
Publication: US US20180271833A1
Glycopyrrolate Salts
Application: 16/235,120 →
Publication: US US20190133999A1
Glycopyrrolate Salts
Application: 16/737,747 →
Publication: US US20200138778A1
Glycopyrrolate Salts
Application: 16/917,677 →
Publication: US US20200330430A1
Process for Production of Glycopyrronium Tosylate
Application: 15/895,685 →
Publication: US US20180186735A1
Process for Production of Glycopyrronium Tosylate
Application: 16/798,160 →
Publication: US US20210002219A1
Device and Method for Dispensing a Drug
Patent: 9,440,056 →
Application: 14/869,799 →
Publication: US US20160089526A1
Device and Method for Dispensing a Drug
Application: 15/146,627 →
Publication: US US20160243345A1
Processes for Making, and Methods of Using, Glycopyrronium Compounds
Application: 16/320,999 →
Publication: US US20190161443A1
Processes for Making, and Methods of Using, Glycopyrronium Compounds
Application: 17/145,109 →
Publication: US US20210130289A1
Process for Production of Glycopyrronium Tosylate
Patent: 9,926,270 →
Application: 14/830,638 →
Publication: US US20160052879A1
Carriers, Formulations, Methods for Formulating Unstable Active Agents for External Application and Uses Thereof
Patent: 8,343,945 →
Application: 12/795,164 →
Publication: US US20100310476A1
Carriers, Formulations, Methods For Formulating Unstable Active Agents For External Application And Uses Thereof
Patent: 9,161,916 →
Application: 13/732,024 →
Publication: US US20130189191A1
Oil and Liquid Silicone Foamable Carriers and Formulations
Patent: 8,900,553 →
Application: 12/795,213 →
Publication: US US20110212033A1
Oil and Liquid Silicone Foamable Carriers and Formulations
Patent: 9,549,898 →
Application: 14/504,942 →
Publication: US US20150118164A1
Oil Foamable Carriers and Formulations
Application: 15/999,088 →
Publication: US US20190091149A1
Oil-Based Foamable Carriers and Formulations
Patent: 8,518,376 →
Application: 13/123,213 →
Publication: US US20110268665A1
Oil-Based Foamable Carriers And Formulations
Patent: 9,795,564 →
Application: 13/967,546 →
Publication: US US20140050673A1
Foamable Vehicles and Pharmaceutical Compositions Comprising Aprotic Polar Solvents and Uses Thereof
Patent: 9,884,017 →
Application: 15/639,114 →
Publication: US US20170360705A1
Foamable Vehicles and Pharmaceutical Compositions Comprising Aprotic Polar Solvents and Uses Thereof
Application: 15/883,134 →
Publication: US US20180153804A1
Foamable Vehicles and Pharmaceutical Compositions Comprising Aprotic Polar Solvents and Uses Thereof
Application: 16/236,704 →
Publication: US US20190201339A1
Foamable Vehicles and Pharmaceutical Compositions Comprising Aprotic Polar Solvents and Uses Thereof
Application: 16/443,649 →
Publication: US US20200016077A1
Non Surfactant Hydro-Alcoholic Foamable Compositions, Breakable Foams and Their Uses
Patent: 9,167,813 →
Application: 13/359,709 →
Publication: US US20120213709A1
Non Surfactant Hydro-Alcoholic Foamable Compositions, Breakable Foams And Their Uses
Patent: 9,572,775 →
Application: 14/857,282 →
Publication: US US20160101051A1
Foamable Compositions, Breakable Foams And Their Uses
Application: 15/401,743 →
Publication: US US20170216334A1
Foamable Compositions, Breakable Foams and Their Uses
Application: 16/108,799 →
Publication: US US20190054106A1
Surfactant-Free Water-Free Foamable Compositions, Breakable Foams and Gels and Their Uses
Patent: 8,945,516 →
Application: 13/499,501 →
Publication: US US20130064777A1
Surfactant-Free Water-Free Foamable Compositions, Breakable Foams and Gels and Their Uses
Application: 14/850,655 →
Publication: US US20160101184A1
Surfactant-Free Water-Free Foamable Compositions, Breakable Foams and Gels and Their Uses
Application: 15/915,386 →
Publication: US US20180193469A1
Surfactant-Free Water-Free Foamable Compositions, Breakable Foams and Gels and Their Uses
Application: 16/235,986 →
Publication: US US20190134204A1
Topical Tetracycline Compositions
Patent: 8,871,184 →
Application: 13/499,475 →
Publication: US US20130028850A1
Topical Tetracycline Compositions
Patent: 8,865,139 →
Application: 14/327,040 →
Publication: US US20140328770A1
Topical Tetracycline Compositions
Patent: 8,992,896 →
Application: 14/469,792 →
Publication: US US20150056149A1
Topical Tetracycline Compositions
Patent: 9,675,700 →
Application: 14/595,882 →
Publication: US US20150190409A1
Topical Tetracycline Compositions
Application: 15/591,733 →
Publication: US US20170340743A1
Topical Tetracycline Compositions
Application: 15/913,574 →
Publication: US US20180193468A1
Topical Tetracycline Compositions
Application: 16/235,964 →
Publication: US US20190134203A1
Topical Tetracycline Compositions
Application: 16/387,407 →
Publication: US US20190262456A1
Topical Tetracycline Compositions
Application: 16/578,252 →
Publication: US US20200016271A1
Surfactant-Free, Water-Free Formable Composition and Breakable Foams and Their Uses
Application: 13/499,709 →
Publication: US US20130011342A1
Surfactant-Free, Water-Free Formable Composition and Breakable Foams and Their Uses
Application: 16/019,623 →
Publication: US US20190000980A1
Compositions, Gels and Foams with Rheology Modulators and Uses Thereof
Patent: 8,618,081 →
Application: 13/100,724 →
Publication: US US20110281827A1
Compositions, Gels and Foams with Rheology Modulators and Uses Thereof
Application: 14/078,746 →
Publication: US US20140066524A1
Compositions, Gels and Foams with Rheology Modulators and Uses Thereof
Application: 16/280,921 →
Publication: US US20190231886A1
Compositions, Gels and Foams with Rheology Modulators and Uses Thereof
Application: 16/387,381 →
Publication: US US20190275157A1
Methods for Accelerated Return of Skin Integrity and for the Treatment of Impetigo
Patent: 9,849,142 →
Application: 13/831,396 →
Publication: US US20130225536A1
Method for Healing of an Infected Acne Lesion without Scarring
Application: 15/816,850 →
Publication: US US20180147218A1
Compositions and Methods for Treating Rosacea and Acne
Application: 15/699,692 →
Publication: US US20180064638A1
Compositions and Methods for Treating Rosacea and Acne
Application: 16/508,611 →
Publication: US US20200016068A1
Compositions and Methods for Treating Rosacea and Acne
Application: 17/075,217 →
Publication: US US20210205212A1
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Mar 1, 2013
From: STATLER, JOHN ALLAN; SHAW, ANTHONY ADRIAN; IMBERT, DELPHINE CAROLINE
To: DERMIRA, INC.
Reel/Frame 029903/0112 →
Assignment of Assignor's Interest Mar 1, 2013
From: APTUIT (WEST LAFAYETTE), LLC
To: DERMIRA, INC.
Reel/Frame 029903/0163 →
Assignment of Assignor's Interest Mar 1, 2013
From: ANDRES, PATRICIA; MCQUEEN, LISA LYNN; NELSON, JENNIFER LEIGH; BOERRIGTER, STEPHAN XANDER MATTHEUS
To: APTUIT (WEST LAFAYETTE), LLC
Reel/Frame 029903/0140 →
Assignment of Assignor's Interest Sep 12, 2013
From: ANDRES, PATRICIA; MCQUEEN, LISA LYNN; NELSON, JENNIFER LEIGH; BOERRIGTER, STEPHAN XANDER MATTHEUS
To: APTUIT LLC
Reel/Frame 031191/0096 →
Assignment of Assignor's Interest Sep 12, 2013
From: STATLER, JOHN ALLAN; IMBERT, DELPHINE CAROLINE; SHAW, ANTHONY ADRIAN
To: DERMIRA, INC.
Reel/Frame 031191/0222 →
Assignment of Assignor's Interest Sep 12, 2013
From: STATLER, JOHN ALLAN; IMBERT, DELPHINE CAROLINE; SHAW, ANTHONY ADRIAN
To: DERMIRA, INC.
Reel/Frame 031191/0178 →
Assignment of Assignor's Interest Sep 12, 2013
From: ANDRES, PATRICIA; MCQUEEN, LISA LYNN; NELSON, JENNIFER LEIGH; BOERRIGTER, STEPHAN XANDER MATTHEUS
To: APTUIT, LLC
Reel/Frame 031191/0206 →
Assignment of Assignor's Interest Sep 17, 2013
From: APTUIT, LLC
To: DERMIRA, INC.
Reel/Frame 031222/0904 →
Assignment of Assignor's Interest Sep 17, 2013
From: APTUIT LLC
To: DERMIRA, INC.
Reel/Frame 031222/0898 →
Assignment of Assignor's Interest Jan 12, 2015
From: STATLER, JOHN ALLAN; SHAW, ANTHONY ADRIAN; IMBERT, DELPHINE CAROLINE; NELSON, JENNIFER LEIGH
To: DERMIRA, INC.
Reel/Frame 034684/0826 →
Assignment of Assignor's Interest Jan 21, 2015
From: MCQUEEN, LISA LYNN
To: DERMIRA, INC.
Reel/Frame 034768/0529 →
Security Interest Dec 7, 2018
From: DERMIRA, INC.
To: ATHYRIUM OPPORTUNITIES III ACQUISITION LP
Reel/Frame 047701/0465 →
Patent Security Agreement Jul 30, 2019
From: FOAMIX PHARMACEUTICALS LTD
To: PERCEPTIVE CREDIT HOLDINGS II, LP
Reel/Frame 049912/0045 →
Assignment of Assignor's Interest Oct 18, 2019
From: TAMARKIN, DOV; GAZAL, ELANA; KEYNAN, RITA; EINI, MEIR
To: FOAMIX LTD.
Reel/Frame 050757/0874 →
Change of Name Oct 18, 2019
From: FOAMIX LTD.
To: FOAMIX PHARMACEUTICALS, LTD.
Reel/Frame 050767/0415 →
Assignment of Assignor's Interest Jan 13, 2020
From: HAZOT, YOHAN; BERMAN, TAL; ZAILER, JANA; AMSALEM, ORIT
To: FOAMIX PHARMACEUTICALS LTD.
Reel/Frame 051491/0595 →
Release of Security Interest Feb 20, 2020
From: ATHYRIUM OPPORTUNITIES III ACQUISITION LP
To: DERMIRA, INC.
Reel/Frame 051882/0260 →
Patent Security Agreement Mar 9, 2020
From: FOAMIX PHARMACEUTICALS LTD.
To: PERCEPTIVE CREDIT HOLDINGS II, LP
Reel/Frame 052130/0966 →
Change of Name Sep 18, 2020
From: FOAMIX LTD.
To: FOAMIX PHARMACEUTICALS LTD.
Reel/Frame 053818/0734 →
Assignment of Assignor's Interest Sep 18, 2020
From: TAMARKIN, DOV; GAZAL, ELANA; KEYNAN, RITA; EINI, MEIR
To: FOAMIX LTD.
Reel/Frame 053818/0693 →
Assignment of Assignor's Interest Oct 9, 2020
From: TAMARKIN, DOV; GAZAL, ELANA; PAPIASHVILI, IRAKLIY; HAZOT, YOHAN
To: FOAMIX LTD.
Reel/Frame 054018/0357 →
Change of Name Oct 9, 2020
From: FOAMIX LTD.
To: FOAMIX PHARMACEUTICALS, LTD.
Reel/Frame 054041/0511 →
Change of Name Nov 4, 2020
From: FOAMIX PHARMACEUTICALS LTD.
To: VYNE PHARMACEUTICALS LTD.
Reel/Frame 054306/0387 →
Assignment of Assignor's Interest Feb 4, 2021
From: VYNE PHARMACEUTICALS LTD.
To: VYNE THERAPEUTICS INC.
Reel/Frame 055215/0298 →
Patent Security Agreement Feb 17, 2021
From: VYNE THERAPEUTICS INC.
To: PERCEPTIVE CREDIT HOLDINGS II, LP
Reel/Frame 055326/0009 →